If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Journal of the American Geriatrics SocietyVolume 49 Issue 4, Pages 351 - 359 Published Online: 21 Dec 2001 Journal compilation 2010 The American Geriatrics Society/Wiley Periodicals, Inc.
Abstract | References | Full Text: HTML, PDF (Size: 783K) | Related Articles | Citation Tracking A Randomized Clinical Trial of Outpatient Geriatric Evaluation and Management Copyright American Geriatrics Society KEYWORDS geriatric evaluation and management • randomized trial • function • health services
J Am Geriatr Soc 49:351–359, 2001.
ABSTRACTOBJECTIVES: To measure the effects of outpatient geriatric evaluation and management (GEM) on high-risk older persons' functional ability and use of health services. DESIGN: Randomized clinical trial. SETTING: Ambulatory clinic in a community hospital. PARTICIPANTS: A population-based sample of community-dwelling Medicare beneficiaries age 70 and older who were at high risk for hospital admission in the future (N = 568). INTERVENTION: Comprehensive assessment followed by interdisciplinary primary care. MEASUREMENTS: Functional ability, restricted activity days, bed disability days, depressive symptoms, mortality, Medicare payments, and use of health services. Interviewers were blinded to participants' group status. RESULTS: Intention-to-treat analysis showed that the experimental participants were significantly less likely than the controls to lose functional ability (adjusted odds ratio (aOR) = 0.67, 95% confidence interval (CI) = 0.47–0.99), to experience increased health-related restrictions in their daily activities (aOR = 0.60, 95% CI = 0.37–0.96), to have possible depression (aOR = 0.44, 95% CI = 0.20–0.94), or to use home healthcare services (aOR = 0.60, 95% CI = 0.37–0.92) during the 12 to 18 months after randomization. Mortality, use of most health services, and total Medicare payments did not differ significantly between the two groups. The intervention cost $1,350 per person. CONCLUSION: Targeted outpatient GEM slows functional decline. |